Viewing Study NCT04054518


Ignite Creation Date: 2025-12-25 @ 4:57 AM
Ignite Modification Date: 2026-01-02 @ 9:54 AM
Study NCT ID: NCT04054518
Status: UNKNOWN
Last Update Posted: 2019-08-13
First Post: 2019-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Durvalumab as Maintenance Following Chemoradiation for Unresectable Esophageal Squamous Cell Carcinoma
Sponsor: Tiago Biachi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module